a public good project by the
Synthesis
Company
of California

© 2026

Nigel J. Liverton | doi.page

0 works0 citations0 h-index

Nigel J. Liverton

Cancer Research Center(US)Tri-Institutional Therapeutics Discovery Institute(US)Disco (Germany)(DE)

Publications by Year

Research Areas

Hepatitis C virus research, HIV/AIDS drug development and treatment, Ion channel regulation and function, Chemical Synthesis and Analysis, Biochemical and Molecular Research

Most-Cited Works

→ Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor(2002)268 cited
→ MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants(2012)254 cited
→ Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor(2012)201 cited
→ Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase(1999)196 cited
→ Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor(2010)176 cited
→ MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease(2009)141 cited

→ Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease(2008)

134 cited

→ Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists(1998)114 cited

→ Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors(2011)106 cited

→ A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease(2012)99 cited